In this study, we found that overexpression of tumor galectin-1 was the most significant prognosticator to predict worse LRPFS in patients with lung adenocarcinoma after thoracic radiation therapy without concurrent chemotherapy. The gene discussed is LGALS1; the disease is lung adenocarcinoma.